Acute and subchronic toxicity of FCD, a soybean extract combined with l-carnitine, in Sprague-Dawley rats

Regulatory Toxicology and Pharmacology

Volumn 59, Issue 2, 2011, Pages 285-292

  Che, Jeong Hwan ^a   Kwon, Euna ^a   Kim, Seung Hyun ^a   You, Ji Ran ^a   Kim, Bae Hwan ^b   Lee, Sang Jun ^c   Chung, Jin Ho ^d   Kang, Byeong Cheol ^a,d  

^a Seoul National University Hospital   (South Korea)

^b Keimyung University   (South Korea)

^c AmorePacific Corporation   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Acute toxicity; L Carnitine; Soybean extract; Subchronic toxicity

Indexed keywords

ANTIOBESITY AGENT; CALCIUM; CHLORIDE; NITROGEN; PHOSPHORUS; POTASSIUM; SOYBEAN EXTRACT PLUS CARNITINE; UNCLASSIFIED DRUG; UREA;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CALCIUM BLOOD LEVEL; CHLORIDE BLOOD LEVEL; CHRONIC TOXICITY; CONTROLLED STUDY; FEMALE; FLUID INTAKE; FOOD INTAKE; HISTOPATHOLOGY; MALE; NONHUMAN; ORGAN WEIGHT; PARTIAL THROMBOPLASTIN TIME; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TOXICITY TESTING; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION;

ACUTE TOXICITY TESTS; ANIMALS; BETA-GLUCANS; BODY WEIGHT; CARNITINE; FEMALE; ISOFLAVONES; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS; TOXICITY TESTS, CHRONIC;

GLYCINE MAX; MUS; RATTUS;

EID: 79952073850     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.11.001     Document Type: Article

References (27)

1. Anderson G.H., Moore S.E. Dietary proteins in the regulation of food intake and body weight in humans. J. Nutr. 2004, 134:974S-979S.
2. Bhathena S.J., Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr. 2002, 76:1191-1201.
3. Cederroth C.R., et al. A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environ. Health Perspect. 2007, 115:1467-1473.
4. Cha Y.S. Effects of l-carnitine on obesity, diabetes, and as an ergogenic aid. Asia Pac. J. Clin. Nutr. 2008, 17(Suppl. 1):306-308.
5. Delclos K.B., et al. Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod. Toxicol. 2001, 15:647-663.
6. Flynn K.M., et al. Effects of genistein exposure on sexually dimorphic behaviors in rats. Toxicol. Sci. 2000, 55:311-319.
7. Fritz W.A., et al. Dietary diethylstilbestrol but not genistein adversely affects rat testicular development. J. Nutr. 2003, 133:2287-2293.
8. Guan L., et al. Developmental and reproductive toxicity of soybean isoflavones to immature SD rats. Biomed. Environ. Sci. 2008, 21:197-204.
9. Hidaka S., et al. Evaluation of a soybean product fujiflavone P40 as an antiosteoporotic agent in rats. Phytother. Res. 2003, 17:112-119.
10. Kim S., et al. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα. Mol. Cell. Endocrinol. 2004, 220:51-58.
11. Klita P.T., et al. Effects of alfalfa root saponins on digestive function in sheep. J. Anim. Sci. 1996, 74:1144-1156.
12. Lamartiniere C.A., et al. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol. Sci. 2002, 65:228-238.
13. Larkin T., et al. The key importance of soy isoflavone bioavailability to understanding health benefits. Crit. Rev. Food Sci. Nutr. 2008, 48:538-552.
14. Martini M.C., et al. Effects of soy intake on sex hormone metabolism in premenopausal women. Nutr. Cancer 1999, 34:133-139.
15. Mun E., et al. l-Carnitine reduces obesity caused by high-fat diet in C57BL/6J mice. Food Sci. Biotechnol. 2007, 16:228-233.
16. Murosaki S., et al. A combination of caffeine, arginine, soy isoflavones, and l-carnitine enhances both lipolysis and fatty acid oxidation in 3T3-L1 and HepG2 cells in vitro and in KK mice in vivo. J. Nutr. 2007, 137:2252-2257.
17. Nagarajan S., et al. Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J. Nutr. 2008, 138:332-337.
18. Orgaard A., Jensen L. The effects of soy isoflavones on obesity. Exp. Biol. Med. (Maywood) 2008, 233:1066-1080.
19. Penza M., et al. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 2006, 147:5740-5751.
20. Potter S.M., et al. Protein-saponin interaction and its influence on blood lipids. J. Agric. Food Chem. 1993, 41:1287-1291.
21. Richelle M., et al. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J. Nutr. 2002, 132:2587-2592.
22. Shin E.S., et al. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and l-carnitine. Eur. J. Nutr. 2006, 45:159-164.
23. Shin E.S., et al. Genistein downregulates SREBP-1 regulated gene expressions through the inhibition of the site-1 protease expression in HepG2 cells. J. Nutr. 2007, 137:1127-1131.
24. Song W.O., et al. Soy isoflavones as safe functional ingredients. J. Med. Food 2007, 10:571-580.
25. Steiner C., et al. Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br. J. Nutr. 2008, 99(Suppl. 1):ES78-ES108.
26. Velasquez M.T., Bhathena S.J. Role of dietary soy protein in obesity. Int. J. Med. Sci. 2007, 4:72-82.
27. Yang J.Y., et al. Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat diet. J. Med. Food 2006, 9:459-467.